Key result
A 70-year-old woman presenting with concurrent acute myocardial infarction and acute cerebral infarction was treated with intravenous tissue plasminogen activator but ultimately decompensated and died.
Why the study?
Concurrent myocardial infarction and acute cerebral infarction is a rare and poorly studied phenomenon that presents a challenge to treat because both conditions are life threatening with narrow therapeutic windows.
Population
One 70 year old female presenting with concurrent stroke and acute myocardial infarction
Design
Case report
Authors
Loading...
tPA in concurrent AMI and cerebral infarction may prove fatal; systematic review leaves optimal reperfusion strategy unresolved.
Case Report (n=1)
Concurrent acute myocardial infarction and acute cerebral infarction is a rare, life-threatening condition with narrow therapeutic windows and challenging management.
Khairy et al. (2021) conducted a case report in Concurrent acute myocardial infarction and acute cerebral infarction (n=1). Intravenous tissue plasminogen activator (IV tPA) was evaluated on Clinical outcome. A 70-year-old woman presenting with concurrent acute myocardial infarction and acute cerebral infarction was treated with intravenous tissue plasminogen activator but ultimately decompensated and died.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: